Marjo Nylund
MSc
Turku PET Centre marjo.k.nylund@utu.fi +358 29 450 4743 +358 50 472 8266 Itäinen Pitkäkatu 4 Turku ORCID identifier: https://orcid.org/0000-0001-6695-5684 |
Publications 
2 of 2
- Drug reaction with eosinophilia and systemic symptoms after ocrelizumab therapy (2020)
- Multiple Sclerosis and Related Disorders
(B1 Non-refereed article in a scientific journal) - Frequency and etiology of acute transverse myelitis in Southern Finland (2020)
- Multiple Sclerosis and Related Disorders
(A1 Refereed original research article in a scientific journal) - Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging (2020)
- Neurology, Neuroimmunology and Neuroinflammation
(A1 Refereed original research article in a scientific journal) - Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland (2020)
- Multiple Sclerosis and Related Disorders
(A1 Refereed original research article in a scientific journal) - Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity (2020)
- Multiple Sclerosis
(A1 Refereed original research article in a scientific journal) - Natalizumab treatment reduces microglial activation in the white matter of the MS brain (2019)
- Neurology, Neuroimmunology and Neuroinflammation
(A1 Refereed original research article in a scientific journal) - Rituksimabi MS-taudin hoidossa (2019)
- Duodecim
(A1 Refereed original research article in a scientific journal) - Evaluation of microglial activation in multiple sclerosis patients using positron emission tomography (2018)
- Frontiers in Neurology
(A2 Refereed review article in a scientific journal ) - Monoklonaaliset vasta-aineet MS-taudin hoidossa (2018)
- Duodecim
(A2 Refereed review article in a scientific journal )
UTU Research Portal